CordenPharma increases xRNA-based capabilities with LNP …
WEBJun 6, 2022 · News and analysis on the clinical development and manufacture of large molecule drugs. CDMO CordenPharma has increased its xRNA capabilities at its sterile injectable facility in Caponago, Italy: with a €10m ($10.7m) investment in new Lipid Nanoparticle (LNP) formulation, development and production areas. The expansion at the site near Milan ...
Boehringer Ingelheim inaugurates Vienna production facility
WEBOct 11, 2021 · Roche’s Actemra/RoActemra approved for treatment of severe COVID-19 in the EU. Chinook Therapeutics creates JV for kidney disease therapies in China. Boehringer Ingelheim has inaugurated a state-of-the-art biopharmaceutical production facility in Vienna, Austria: representing the single largest investment in the company’s history.
Building a biotech hub: Switzerland focuses on mRNA, CGT and …
WEBSep 8, 2021 · There are 314 biotech companies in Switzerland: broken down into 251 developers and 63 suppliers. Swiss life science exports were valued at CHF 99.1bn ($108bn USD) in 2020 and accounted for 44% of total exports. The sector has grown by a factor of 4.5 since 2000, when life sciences accounted for 17% of …
Fujifilm to invest $1.6bn and make its Hillerød facility in Denmark …
WEBJun 30, 2022 · Almost all of the investment will be ploughed into FDB's site in Hillerød, Denmark, which Fujifilm acquired from Biogen in August 2019.. Some 450 jobs will be created at the Danish campus, to add to the 1,055 …
GE Healthcare Life Sciences completes transition into Cytiva
WEBApr 1, 2020 · Now, with the deal complete, GE Healthcare Life Sciences has emerged at the other side rebranded as Cytiva. The company will retain the same staff, which means that it will have 7,000 employees and possess operations in 40 countries, becoming part of Danaher Corporation Life Sciences platform. CEO and president of Cytiva, Emmanuel Ligner, spoke ...
BioNTech acquires GMP manufacturing site in Singapore
WEBNov 14, 2022 · News and analysis on the clinical development and manufacture of large molecule drugs. BioNTech will create an mRNA facility in Singapore through the acquisition of a Novartis site: which will become its Regional Headquarters and production center for the Asia Pacific region. The facility is expected to be fully operational late next year ...
French biotech raises €5m, looks to restore patient response to ...
WEBDec 1, 2021 · The diagnostic test is under development. As for colon cancer, we have several candidates in preclinical test,”. EverImmune, a biotech based near Paris, and specialized in the development of live biotherapeutic products in the field of microbiota oncology, has raised €5m (US$5.7m) in a Series A …
Protagen, BioAnalytix, and GeneWerk unveil combined CRO …
WEBJan 13, 2022 · Protagen Protein Services, a global analytic CRO and expert in protein science, and BioAnalytix, a US-based advanced analytics and data analysis firm, aligned in April 2019. GeneWerk, with capabilities in vector safety, integration site analysis, and bioinformatics, merged into the group in 2021. ProtaGene is …
FDA releases draft guidance for cell and gene therapies
WEBApr 6, 2022 · The FDA has released two draft guidance documents: for human gene therapy products incorporating human genome editing, and for CAR T cell products. Published on March 15, the guidance documents cover recommendations including product manufacturing and clinical trial design. The draft guidance, ‘Human Gene Therapy Products Incorporating Human ...
GSK expands its clinical trial manufacturing capacity at dedicated …
WEBMar 15, 2021 · GSK expands its clinical trial manufacturing capacity at dedicated CGT facility in UK. Cell and Gene Therapy Catapult (CGT Catapult) says that GSK will leverage its Stevenage facility to perform GMP cell processing and accelerate its cell and gene therapy pipeline for clinical trials. Through this agreement, GSK is …
Skip to content